Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Sigma-Aldrich To Add High-Potency Plant
September 8, 2008
| A version of this story appeared in
Volume 86, Issue 36
Sigma-Aldrich's SAFC Pharma unit will spend $30 million to build a new high-potency active pharmaceutical ingredient (HPAPI) plant in Verona, Wis., near its existing Madison facility. The company says it is purchasing 15 acres on which it will build a 45,000-sq-ft facility with reactors of up to 4,000 L in size. "Currently, there is minimal manufacturing capacity to support market demand for large-scale HPAPI production," says Dave Feldker, vice president of sales and manufacturing for SAFC Pharma. The new plant is expected to be completed by the end of next year.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter